Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Cancers”

6,026 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,026 results

Early research (Phase 1)Study completedNCT01585701
What this trial is testing

Phase I Study of AT13148, a Novel AGC Kinase Inhibitor

Who this might be right for
Advanced Solid Tumours
Cancer Research UK 56
Early research (Phase 1)Ended earlyNCT02673736
What this trial is testing

PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Who this might be right for
Solid TumorsTenosynovial Giant Cell TumorSynovitis, Pigmented Villonodular
Plexxikon 11
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Early research (Phase 1)Study completedNCT00396864
What this trial is testing

Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma

Who this might be right for
CancerLymphomas
Celgene 51
Testing effectiveness (Phase 2)Ended earlyNCT05949632
What this trial is testing

INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Incyte Corporation 5
Early research (Phase 1)Looking for participantsNCT07101601
What this trial is testing

Study of DM5167 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Breast Cancer
DIGMBIO 58
Early research (Phase 1)Study completedNCT03758001
What this trial is testing

First in Human Study of IBI101 in Chinese Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 38
Early research (Phase 1)Looking for participantsNCT06239467
What this trial is testing

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Who this might be right for
Advanced CancerBreast CancerAdvanced Solid Tumors+1 more
OnKure, Inc. 200
Early research (Phase 1)Ended earlyNCT04553692
What this trial is testing

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

Who this might be right for
Solid TumorColorectal CancerNon Hodgkin Lymphoma+5 more
IGM Biosciences, Inc. 272
Very early researchUnknownNCT05941936
What this trial is testing

A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

Who this might be right for
Solid Tumor
Suzhou BlueHorse Therapeutics Co., Ltd. 5
Not applicableUnknownNCT03927599
What this trial is testing

Advanced Refractory Solid Tumors With TP53 Mutations Register Study

Who this might be right for
Solid Tumor, Adult
Tianjin Medical University Second Hospital 100
Early research (Phase 1)Study completedNCT01280487
What this trial is testing

A Safety Study of Oral ZSTK474 in Patients With Cancer

Who this might be right for
Neoplasms
Zenyaku Kogyo Co., Ltd. 39
Early research (Phase 1)Study completedNCT01421004
What this trial is testing

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsExcluding Breast Cancer
Novartis Pharmaceuticals 166
Early research (Phase 1)Study completedNCT03922204
What this trial is testing

Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Who this might be right for
Advanced CancerSolid Tumor, AdultB-cell Lymphoma, Adult
Merus B.V. 72
Early research (Phase 1)Looking for participantsNCT06132828
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Zhejiang Doer Biologics Co., Ltd. 216
Early research (Phase 1)Active Not RecruitingNCT05163028
What this trial is testing

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Who this might be right for
Non Small Cell Lung CancerColorectal CancerPancreatic Cancer+4 more
HUYABIO International, LLC. 42
Early research (Phase 1)UnknownNCT04294576
What this trial is testing

Safety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Locally Advanced/Metastatic Solid Tumors
BJ Bioscience, Inc. 92
Early research (Phase 1)Ended earlyNCT00337376
What this trial is testing

The mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Who this might be right for
Advanced Solid Cancers
Yale University 23
Early research (Phase 1)Study completedNCT00670189
What this trial is testing

BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer

Who this might be right for
Hedgehog PathwaySmoothenedBasal Cell Carcinoma (BCC)+1 more
Bristol-Myers Squibb 53
Early research (Phase 1)Study completedNCT01149720
What this trial is testing

Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Daiichi Sankyo 24
Load More Results